发明名称 СПОСОБ ЛЕЧЕНИЯ РАКА ПРЯМОЙ КИШКИ
摘要 FIELD: medicine, oncology. ^ SUBSTANCE: in pre-surgical period in the 1st, 3d, 5th d of a 5-d-long irradiation course it is necessary to carry out a seance of distance gamma-therapy at single focal dosage (SFD) being 5 Gy at the background of a double intake of capecytabin at its daily dosage of 1.5 g/sq. m body surface. In the 2nd and 4th d at the background of a double intake of capecytabin at the same dosage, one should intrarectally introduce metronidasol at the rate of 10 g/sq. m body surface and after a 6-h-long exposure one should carry out a seance of distance gamma-therapy at SFD being 5 Gy. Moreover, metronidasol should be introduced as a composite mixture at the following ratios of the ingredients, weight%: metronidasol 12-22; sodium alginate 4-6; dimethyl sulfoxide 2; distilled water - up to 100. The innovation provides taking antilogarithms of the effect of radiomodifiers of different direction at the background of radiation therapy and, thus, the absence of locoregional relapses for the period of 2 yr, the decrease in the onset of distant metastases and the increased frequency in achieving radial pathomorphosis of degree III in the tumor. ^ EFFECT: higher efficiency of therapy. ^ 1 ex
申请公布号 RU2005139045(A) 申请公布日期 2007.06.20
申请号 RU20050139045 申请日期 2005.12.15
申请人 Государственное учреждение Российский онкологический научный центр им. Н.Н. Блохина РАМН (RU) 发明人 Барсуков Юрий Андреевич (RU);Олтаржевска  Наталь  Дмитриевна (RU);Ткачев Сергей Иванович (RU);Николаев Андрей Васильевич (RU);Власов Олег Александрович (RU);Кричевский Герман Евсеевич (RU);Левшова Натали  Валентиновна (RU);Кузьмичев Дмитрий Владимирович (RU);Малихов Аркадий Геннадьевич (RU);Семенов Николай Николаевич (RU);Перевощиков Александр Григорьевич (RU);Глебовска  Валери  Владимировна (RU)
分类号 A61N5/00 主分类号 A61N5/00
代理机构 代理人
主权项
地址